NM_000059.4(BRCA2):c.2273del (p.Ser758fs) AND not provided

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Nov 1, 2016
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000486070.1

Allele description [Variation Report for NM_000059.4(BRCA2):c.2273del (p.Ser758fs)]

NM_000059.4(BRCA2):c.2273del (p.Ser758fs)

Gene:

BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

13q13.1

Genomic location:

Preferred name:

NM_000059.4(BRCA2):c.2273del (p.Ser758fs)

HGVS:

NC_000013.11:g.32336628del
NG_012772.3:g.26149del
NM_000059.4:c.2273delMANE SELECT
NP_000050.3:p.Ser758fs
LRG_293:g.26149del
NC_000013.10:g.32910765del
NM_000059.3:c.2273delG
p.(Ser758IlefsTer14)

Protein change:

S758fs

Links:

dbSNP: rs1064795934

NCBI 1000 Genomes Browser:

rs1064795934

Molecular consequence:

NM_000059.4:c.2273del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000572207	GeneDx	criteria provided, single submitter (GeneDx Variant Classification (06012015))	Pathogenic (Nov 1, 2016)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000572207

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification (06012015))

Pathogenic
(Nov 1, 2016)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From GeneDx, SCV000572207.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This deletion of one nucleotide in BRCA2 is denoted c.2273delG at the cDNA level and p.Ser758IlefsX14 (S758IfsX14) at the protein level. Using alternate nomenclature, this variant would be defined as BRCA2 2501delG. The normal sequence, with the base that is deleted in braces, is GAAAA[G]TCTT. The deletion causes a frameshift which changes a Serine to an Isoleucine at codon 758, and creates a premature stop codon at position 14 of the new reading frame. Although this variant has not, to our knowledge, been reported in the literature, it is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. We consider this variant to be pathogenic.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 1, 2024

ClinVar

Relating variation to medicine